Characteristics influencing outcomes of corneal collagen crosslinking for keratoconus and ectasia: implications for patient selection

J Cataract Refract Surg. 2013 Aug;39(8):1133-40. doi: 10.1016/j.jcrs.2013.06.007.

Abstract

Purpose: To determine preoperative patient characteristics that may predict topography and visual acuity outcomes of corneal collagen crosslinking (CXL).

Setting: Cornea and refractive surgery practice.

Design: Cohort study.

Methods: Crosslinking was performed in eyes with keratoconus or corneal ectasia. Multiple regression and odds ratio analyses were performed to determine independent predictors of changes in topography-derived maximum keratometry (K) and corrected distance visual acuity (CDVA) 1 year postoperatively. Preoperative characteristics included sex, age, uncorrected distance visual acuity (UDVA), CDVA, maximum keratometry (K), corneal thickness, corneal haze, disease group, and cone location. Postoperative improvement in maximum K was defined as flattening of 2.0 diopters (D) or more and worsening as steepening of 1.0 D or more. Improvement in CDVA was defined as a gain of 2 lines or more and worsening as a loss of 1 line or more.

Results: The study comprised 104 eyes (66 keratoconus; 38 corneal ectasia). Eyes with a preoperative CDVA of 20/40 or worse were 5.9 times (95% confidence interval [CI], 2.2-6.4) more likely to improve 2 Snellen lines or more. Eyes with a maximum K of 55.0 D or more were 5.4 times (95% CI, 2.1-14.0) more likely to have topographic flattening of 2.0 D or more. No preoperative characteristics significantly predicted worsening of visual acuity or corneal topography.

Conclusions: Patients with worse preoperative CDVA and higher K values, particularly with a CDVA of 20/40 or worse or a maximum K of 55.0 D or more, were most likely to have improvement after CXL. No preoperative characteristics were predictive of CXL failure.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Cohort Studies
  • Collagen / metabolism*
  • Corneal Stroma / metabolism*
  • Corneal Topography
  • Cross-Linking Reagents / therapeutic use*
  • Dilatation, Pathologic / drug therapy
  • Dilatation, Pathologic / etiology
  • Dilatation, Pathologic / metabolism
  • Female
  • Humans
  • Keratoconus / drug therapy*
  • Keratoconus / etiology
  • Keratoconus / metabolism
  • Keratomileusis, Laser In Situ
  • Male
  • Middle Aged
  • Odds Ratio
  • Patient Selection
  • Photochemotherapy*
  • Photorefractive Keratectomy
  • Photosensitizing Agents / therapeutic use*
  • Prospective Studies
  • Riboflavin / therapeutic use*
  • Treatment Outcome
  • Ultraviolet Rays
  • Visual Acuity / physiology
  • Young Adult

Substances

  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin